MIP Diagnostics is a technology leader in the field of Molecularly Imprinted Polymers (MIPs). The business has developed a novel, proprietary design and development process to make nanoMIPs; nanostructured polymer particles typically containing a single binding site for the target of choice. NanoMIPs are opening the door to a more diverse range of commercial applications, namely as a viable alternative to antibodies within the IVD sector, offering high performance, robust characteristics and a reliable, ethical supply.